Table 1.
Some characteristics of five patients with lymphoproliferative disease and chronic pain treated with SCS.
| No. of Patients | Disease | Sex | Age | PS | Prognostic index | Expected survival | NPR score before TX | NPR score after TX |
|---|---|---|---|---|---|---|---|---|
| 1 | CLL | M | 70 | 2 | CLL-IPI 1 |
5-years survival: 79.3% |
7 | 2 |
| 2 | CLL | F | 65 | 2 | CLL-IPI 2 |
5-years survival: 93.2% |
8 | 2 |
| 3 | WM | F | 53 | 2 | ISSWM 0 |
Median survival: 142 months |
10 | 5 |
| 4 | FL | M | 70 | 2 | FLIPI 1 |
10-years overall survival: approximately 70% | 6 | 1 |
| 5 | FL | M | 69 | 2 | FLIPI 1 |
10-years overall survival: approximately 70% | 6 | 1 |